Ventilatory Parameters and Inflammatory Responses of Neonates Ventilated by Different Modes of Ventilation

November 19, 2013 updated by: Ebru Ergenekon, Gazi University

Determination of Ventilatory Parameters and Inflammatory Responses of Neonates Who Are Ventilated by Volume Guarantee Combined With Synchronized Intermittent Mandatory Ventilation or Pressure Support Ventilation

The main purpose of this study is to investigate effects of SIMV+VG (synchronized intermittent mandatory ventilation+volume guarantee) or PSV+VG (pressure support ventilation+volume guarantee) ventilation on vital signs, patient - mechanical ventilation synchrony, ventilation parameters and inflammatory mediators in neonates.

Study Overview

Detailed Description

Term or preterm neonates may need mechanical ventilation due to different etiologies. In all patients aim of mechanical ventilation is to promote pulmonary gas exchange, reduce the respiratory work of patient. Ideal mechanical ventilation must minimize pulmonary trauma with low inspiratory pressures that obtains adequate and constant tidal volumes. Ventilation associated pulmonary injury is an important subject that must be considered during mechanical ventilation. Atelectotrauma, volutrauma, barotrauma and biotrauma must be monitored. Volutrauma, barotrauma and oxygen toxicity cause cytokine increase that results in biotrauma. This parenchymal inflammation is a risk factor for chronic lung disease which is an important morbidity of ventilated neonates.

From past to present neonates were ventilated with different ventilation modes including IMV (Intermittent Mandatory Ventilation), SIMV, A/C (Assist Control Ventilation), PSV,HFV (High Frequency Ventilation). Both PSV and SIMV are patient trigger ventilation modes but SIMV is a time cycled and PSV is a flow cycled mode. In recent years hybrid techniques were developed to combine beneficial features of volume and pressure limited ventilation. In commercial ventilation devices these techniques have different names as volume guaranteed pressure limited ventilation (Drager Babylog 8000), pressure regulated volume controlled ventilation (Siemens servo 3000), volume guaranteed pressure support ventilation (VIP Bird Gold).

Since there is not a standard protocol for mechanical ventilation of neonates different countries and even different NICU's use different ventilation protocols.

Literature supports volume targetted ventilation to reduce barotrauma with low maximum inspiratory pressures and to reduce volutrauma with constant tidal volumes. When A/C+VG and SIMV+VG were compared in a crossover trial, more constant tidal volumes were obtained in A/C mode. Inflammatory cytokines have also been measured in different groups of patients with variable ventilatory management techniques. So far there has not been a randomized study published comparing VG+SIMV with VG+PSV in newborns with regards to tidal volume , peak inspiratory pressure variability,or inflammatory cytokines. Therefore in this study the investigators aimed to compare these two ventilation modes with regards to short term outcome.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ankara
      • Besevler, Ankara, Turkey, 06500
        • Gazi University Hospital, Department of Pediatrics, Division of Newborn Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 day (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • neonates with respiratory distress who need mechanical ventilation
  • gestational age less than or equal to 37 weeks
  • neonates who need mechanical ventilation within first 24 hours

Exclusion Criteria:

  • neonates who need mechanical ventilation other than conventional ventilation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: PSV+VG
Neonates who require mechanical ventilation and randomised to pressure support + volume guarantee (PSV+VG) mode
Neonates who need mechanical ventilation will be ventilated with PSV+VG
Other Names:
  • PSV+ VG mode of ventilation
Active Comparator: SIMV+VG
Neonates who require mechanical ventilation and randomised to synchronised intermittant mandatory ventilation + volume guarantee (SIMV+VG) mode
Neonates who need mechanical ventilation will be ventilated with SIMV+VG mode
Other Names:
  • SIMV + VG mode of ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IL-1beta levels in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
IL-6 level in tracheal aspirate
Time Frame: Baseline and 72 hours of mechanical ventilation
Tracheal aspirate will be analyzed for IL6 level and the change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
IL-8 in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
IL-10 level in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
TNF alfa in tracheal aspirate material
Time Frame: Baseline and 72 hours of mechanical ventilation
Tracheal aspirate will be analyzed for the mediator level and change from baseline will be reported
Baseline and 72 hours of mechanical ventilation
tidal volume variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
variability in tidal volume measured with babyview program
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
peak inspiratory pressure variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
variability in peak inspiratory pressure measured with babyview program
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
respiratory rate variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
changes in respiratory rate, tacypnea rate
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
oxygen saturation variability
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
changes in oxygen saturation, desaturation rate, hyperoxy rate
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
lowest carbondioxide level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
ratio of hypocarbic blood gases and least pCo2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
highest carbondioxide level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
ratio of hypercarbic blood gases and highest pCo2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
lowest oxygen level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
ratio of hypoxic blood gases and least pO2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier
highest oxygen level (mmHg)
Time Frame: 72 hours of mechanical ventilation or entire ventilation time if extubated earlier
ratio of hyperoxic blood gases and highest pO2 level
72 hours of mechanical ventilation or entire ventilation time if extubated earlier

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bronchopulmonary dysplasia
Time Frame: 36 weeks corrected age
Oxygen requirement at 36 weeks corrected age
36 weeks corrected age
patent ductus arteriosus
Time Frame: in the first week of post natal life of the patient
Presence of hemodynamically significant patent ductus arteriosus in the first 7 days of life
in the first week of post natal life of the patient
necrotizing enterocolitis
Time Frame: 36 weeks corrected age
Necrotising entercolitis defined by clinical and radiological findings
36 weeks corrected age
intraventricular hemorrhage
Time Frame: during first week
Intraventricular hemorrhage diagnosed by head ultrasound
during first week
pneumothorax
Time Frame: during first 3 days
Air leak diagnosed by chest x-ray
during first 3 days
pulmonary interstitial emphysema
Time Frame: during first week
Air leak diagnosed by x-ray
during first week
pulmonary hemorrhage
Time Frame: during first week
during first week
retinopathy of prematurity
Time Frame: until 36 weeks corrected age
Retinal disease diagnosed by indirect opthtalmoscopic exam
until 36 weeks corrected age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Ebru N Ergenekon, MD, Gazi University, Division of newborn Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

November 1, 2013

Study Completion (Actual)

November 1, 2013

Study Registration Dates

First Submitted

December 20, 2011

First Submitted That Met QC Criteria

January 20, 2012

First Posted (Estimate)

January 23, 2012

Study Record Updates

Last Update Posted (Estimate)

November 20, 2013

Last Update Submitted That Met QC Criteria

November 19, 2013

Last Verified

November 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilator Induced Lung Injury

Clinical Trials on PSV+VG (pressure support ventilation+volume guarantee)

Subscribe